We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Moderna Inc | NASDAQ:MRNA | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.04 | 0.03% | 125.04 | 124.15 | 125.11 | 2,677 | 12:31:33 |
From May 2022 to May 2024
13:50 ET -- Moderna Inc. is one of the most talked about companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The pharmaceutical company said Monday that its updated Covid-19 booster worked against Omicron subvariants BA.4 and BA.5 better than its previous vaccine. Chief Executive Stephane Bancel said that the boosters show neutralizing activity against this increasingly dominant emerging variant, "confirming that updated vaccines have the potential to offer protection as the virus continues to evolve rapidly to escape our immunity." Moderna shares were recently up about 6.2%, at $181.73. Dow Jones & Co. owns Factiva. (susan.solan@wsj.com)
(END) Dow Jones Newswires
November 14, 2022 14:05 ET (19:05 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Moderna Chart |
1 Month Moderna Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
